Endothelial cell integrin α5β1 expression is modulated by cytokines and during migration in vitro

Journal of Cell Science

Volumn 112, Issue 4, 1999, Pages 569-578

  Collo, Ginetta ^a   Pepper, Michael S ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

Angiogenesis; Basic fibroblast growth factor; Extracellular matrix; Leukemia inhibitory factor; Transforming growth facror 1

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CYTOKINE; INTEGRIN; LEUKEMIA INHIBITORY FACTOR; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

ALPHA CHAIN; ANGIOGENESIS; ANIMAL CELL; AORTA; ARTICLE; BETA CHAIN; CATTLE; CELL DENSITY; CELL INTERACTION; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GENE EXPRESSION; MICROVASCULARIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; WOUND HEALING;

ANIMALS; BLOTTING, NORTHERN; CATTLE; CELL LINE; CELL MOVEMENT; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTOR 2; GROWTH INHIBITORS; INTERLEUKIN-6; LEUKEMIA INHIBITORY FACTOR; LYMPHOKINES; PRECIPITIN TESTS; RECEPTORS, FIBRONECTIN; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; WOUND HEALING;

ANIMALIA; BOS TAURUS; BOVINAE;

EID: 0032969073     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Albelda, S. M., Daise, M., Levine, E. M. and Buck, C. A. (1989). Identification and characterization of cell-substratum adhesion receptors on cultured human endothelial cells. J Clin. Invest. 83, 1992-2002.
2. Argraves, W. S., Pytela, R., Suzuki, S., Millan, J. L., Pierschbacher, M. D. and Ruoslahti, E. (1986). cDNA sequences from the alpha subunit of the tibronectin receptor predict a transmembrane domain and a short cytoplasmic peptide. J. Biol Chem. 261, 12922-12924.
3. Argraves, W. S., Suzuki, S., Arai, H., Thompson, K., Pierschbacher, M. D. and Ruoslahti, E. (1987). Amino acid sequence of the human fibronectin receptor. J. Cell Biol. 105, 1183-1190.
4. Basson, C. T., Kocher, O., Basson, M. D., Asis, A. and Madri, J. A. (1992) differential modulation of vascular cell integrin and extracellular matrix expression in vitro by TGF-β correlates with reciprocal effects on cell migration. J. Cell. Physiol. 153 118-128.
5. Britsch. S.. Christ, B. and Jacob, H. J. (1989). The influence of cell-matrix interactions on the development of quail chorioallantoic vascular system. Anal. Embryol. 180. 479-484.
6. 3 for angiogenesis. Science 264, 569-571.
7. 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79, 1157-1164.
8. 3 blocks human breast cancer growth and angiogenesis in human skin. J. Clin. Invest. 96, 1815-1822.
9. Cheng, Y.-F. and Kramer, R. H. (1989). Human microvascular endothelial cells express integrin-relaled complex thet mediate adhesion to the extracellular matrix. J. Cell. Physiol. 139, 275-286.
10. Chrislofori, G. (1997). The role of fibroblast growth factors in tumour progression and angiogenesis. In Tumour Angiogenesis (ed. R. Bicknell, C. E. Lewis and N. Ferrara). pp. 309-331. Oxford University Press.
11. Clark, R. A. F., DellaPelle, P., Manseau, E., Lanigan, J. M., Dvorak, H. F. and Colvin, R. B. (1982a). Blood vessel fibronectin increases in conjunction with endothelial cell proliferation and capillary ingrowth during wound healing. J. Invest. Dermatol. 79, 269-276.
12. Clark, R. A. F., Quinn, J. F., Winn, H. J., Lanigan, J. M., Dellepella, P. and Colvin, R. B. (1982b). Fibronectin is produced by blood vessels in response to injury. J. Exp. Med. 156, 646-651.
13. Clark, R. A. F., Tonnesen, M. G., Gailit, J. and Cheresh, D. A. (1996) Transient functional expression of αvβ3 on vascular cells during wound repair. Am. J. Pathol. 148, 1407-1421.
14. Defilippi, P., van Hinsbergh, V., Bertolotto, A., Rossino, A., Silenfo, L. and Tarone, G. (1991). Differential distribution and modulation of expression of alpha1/beta1 integrin on human endothelial cells. J. Cell Biol. 114, 855-863.
15. Drake, C. J., Davis, L. A. and Little, C. D. (1992). Antibodies to beta I-integrins cause alterations of aortic vasculogenesis. in vivo. Dev. Dynamics i193, 83-91.
16. 3 prevents maturation of blood vassels during embryonic vascularization. J. Cell Sci. 108, 2655-2661.
17. Dvorak, H. F., Brown, L. F., Detmar, M. and Dvorak, A. M. (1995) Vascular Permeability Factor/Vascular Endothelial Growth Factor. microvascular hyperpermeability, and angiogenesis, Am. J. Pathol. 146, 1029-1039.
18. Enenstein, J., Waleh, N. S. and Kramer, R. H. (1992). Basic FGF and TGF-β differentially modulate integrin expression of human microvascular endothelial cells. Exp. Cell Res. 203, 499-503.
19. Folkman, J. (1995). Clinical applications of research on angiogenesis. New Engl. J. Med. 333, 1757-1763.
20. 5 in ocular neovascular diseases. Proc. Natl. Acad. Sci. USA 93, 9764-9769.
21. Frisch, S. M. and Rouslahti, E. (1997). Integrins and anoikis. Curr. Opin. Cell Biol. 9, 701-706.
22. Furie, M. B., Cramer, E. B., Naprstek, B. L. and Silverstein, S. C. (1984). Cultured endothelial cell monolayers that restrict the transendothelial passage of macromoleculcs and electrical current. J. Cell Biol. 98, 1033-1041.
23. Gajdusek, C. M., Luo, Z. and Mayberg, M. R. (1993). Basic fibroblast growth factor and transforming growth factor beta-1 : synergistic mediators of angiogenesis in vitro. J. Cell. Physiol. 157,133-144.
24. George, E. L., Georges-Labouesse, E. N., Patel-King, R. S., Rayburn, H. and Hynes, R. O. (1993). Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development 119, 1079-1091.
25. 1 tibronectin receptor seppress the transformed phenotype of Chinese hamster ovary cells. Cell 60, 849-859.
26. Giancotti, F. G. and Mainiero, F. (1994). Integrin-mediated adhesion and signaling in tumorigenesis. Biochim. Biophys. Acta 1198, 47-64.
27. Hammes, H.-P., Brownlee, M., Jonczyk, A., Sutter, A. and Preissner, K. T. (1996). Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Nature Med. 2, 529-533.
28. Heimark, R. L., Twardzik, D. R. and Schwartz, S. M. (1986). Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets. Science 233, 1078-1080.
29. Huttenlocher, A., Cinsberg, M. H. and Horwitz, A. F. (1996). Modulation of cell migration by integrin-mediated cytoskeletal linkages and ligand-binding affinity. J. Cell Biol. 134, 1551-1562.
30. Hynes, R. O. (1992). Integrins: versatility, modulation, and signalling in cell adhesion. Cell 69, 11-25.
31. Hynes, R. O. (1996). Targeted mutations in cell adhesion genes: what have we learned from them. Dev. Biol. 180, 402-412.
32. Juliano, R. (1996). Cooperation between soluble factors and imegrin-mediated cell anchorage in the control of cell growth and differentiation. Bio Essay 18, 911-917.
33. Klein, S., Giancotti, F. G., Presta, M., Albelda, S. M., Buck, C. A. and Rifkin, D. B. (1993). Basic ribroblast growth factor modulates integrin expression in microvascular endothelial cells. Mol. Biol. Cell. 4, 973-982.
34. Luscinskas, F. W. and Lawler, J. (1994). Integrins as danamic regulators of vascular function. FASEB J. 8, 929-938.
35. Montesano, R. and Orci, L. (1985). Tumor-promoting phorbol esters induce angiogenesis in vitro. Cell 42, 469-477.
36. Montesano, R., Vassalli, J.-D., Baird, A., Guillemin, R. and Orel, L. (1986) Basic ribroblast growth factor induces angiogenesis in vitro. Proc. Natl. Acail. Sci. USA 83, 7297-7301
37. Mignatti, P., Tsuboi, R., Robbins, E. and Rifkin, D. B. (1989). In vtro angiogenesis on the human amniotic membrane: requirements for basic fibroblast growth factor-induced proteases. J. Cell Biol. 108, 671-682.
38. Müller, G., Behrens, J., Nassbaumer, U., Bohlen, P. and Birchmeier, W. (1987). Inhibitory action of transforming growth factor-β on endothelial cells. Proc. Natl. Acad. Sci. USA 84, 5600-5604.
39. Nicosia, R. F. and Bonanno, E. (1991). Inhibition of angiogenesis in vitro by Arg-Gly-Asp-containing synthetic peptide. Am. J. Pathol. 138, 829-833.
40. Nicosia, R. F. (1998). What is the role of vascular endothelial growth factor-related molecules in tumor angiogenesis? Am. J. Pathol. 153, 11-16.
41. Palecek, S. P., Loftus, J. C., Ginsberg, M. H., Lauffenburger, D. A. and Horwitz, A. F. (1997). Integrin-ligand properties govern cell migration speed through cell-substratum adhesiveness. Nature 385. 537-540.
42. Pepper, M. S., Belin, D., Montesano, R., Orci, L. and Vassalli, J.-D. (1990). Transforming growth factor-beta 1 modulates basic ribroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J. Cell Biol. 111, 743-755.
43. Pepper, M. S., Ferrara, N., Orci, L. and Montesano, R. (1992a). Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem. Biophys. Res. Commun. 189. 824-831.
44. Pepper, M. S., Montesano, R., El Aoumari, A., Gros, D., Orci, L. and Meda, P. (1992b). Coupling and connexin 43 expression in microvascular and large vessel endothelial cells. Am. J. Physiol. 262, C1246-C1257.
45. Pepper, M. S., Sappino, P.-A., Montesano, R., Orci, L. and Vassalli, J.-D. (1992c). Plasminogen activator inhibitor-1 is induced in migrating endothelial cells. 7. Cell. Physiol. 153, 129-139.
46. Pepper, M. S., Vassalli, J.-D., Orci, L. and Montesano, R. (1993) Biphasic effect of transforming growth factor-β1 on in vitro angiogenesis. Exp. Ceill Res. 204, 356-363.
47. Pepper, M. S., Vassalli, J.-D., Wilks, J. W., Schweigerer, L., Orci, L. and Montesano R. (1994). Modulation of bovine microvascular endothelial cell proteolytic properties by inhibitors of angiogenesis. J. Cell. Biochem. 55, 419-434.
48. Pepper, M. S., Ferrara, N., Orci, L. and Montesano, R. (1995). Leukemia inhibitory factor (LIF) inhibits in vitro angiogenesis. J. Cell Sci. 108, 73-83.
49. Pepper, M. S., Mandriota, S. J., Vassalli, J.-D., Orci, L. and Montesano, R. (1996). Angiogenesis regulating cytokines: activities and interactions. Attempts to Understand Metastasis Formation. Curr Topics Microbiol. Immunol. 213/11, 31-67.
50. Pepper, M. S. (1997a). Manipulating angiogenesis: from basic science to the bedside. Arterioscl. Thromb. Vasc. Biol. 17, 605-619.
51. Pepper, M. S. (1997b). Transforming growth factor-beta: vasculogenesis, angiogenesis and vessel wall integrity. Cytokine Growth Factor Rev. 8. 21-43.
52. Ponte, P., Gunning, P., Blau, H. and Kedes, L. (1983). Human act in genes are single copy for alpha-skeletal and alpha-cardiac actin but multicopy for beta-and gamma-cytoskeletal genes: 3′' untranslated regions are isotype specific but are conserved in evolution. Mol. Cell. Biol. 3. 1783-1791.
53. Risau, W. and Lemmon, V. (1988). Changes in the vascular extracellular matrix during embryonic vasculogenesis and angiogenesis. Dev. Biol. 125, 441-450.
54. 3 in the disruption of the tumor vasculature induced by TNF and IFN-γ. Nature Med. 4, 408-414.
55. Ruoslahti, E. (1996). RGD and other recognition sequences for integrins. Ann. Rev. Cell Dev. Biol. 12, 697-715.
56. Ruoslahti, E. and Engvall, E. (1997). Integrins and vascular extracellular matrix assembly. J. Clin. Invest. 99, 1149-1152.
57. Sariola, H., Peault, B., LeDouarin, N., Buck, C., Dieterlen-Lièvre, F. and Saxén, L. (1984). Extracellular matrix and capillary ingrowth in interspecies chimeric kidneys. Cell Differ. 15, 43-51.
58. Schreiner, C., Fisher, M., Hussein, S. and Juliano, R. L. (1991). Increased tumorigenity of fibronectin receptor deficient Chinese hamster ovary cell variants. Cancer Res. 51, 1738-1740.
59. 3 integrin. osteopontin, and thrombin. Am. J. Pathol. 149, 293-305.
60. 3 integrin complex on human microvascular endothelial cells. J. Invest. Dermatol. 103, 295-299.
61. Stephens, L. E., Sutherland, A. E., Klimanskaya, I. V., Andrieux, A., Meneses, J., Pedersen, R. A. and Damsky, C. H. (1995). Deletion of β1 integrins in mice results in inner cell mas failure and peri-implantation lethality. Genes Dev. 9, 1883-1895.
62. Suehiro, K., Gailit, J. and Plow, E. F. (1997). Fibrinogen is a ligand for integrin α5β1 on endothelial cells. J. Biol. Chem. 272, 5360-5366.
63. Suzuma, K., Takagi, H., Otani, A. and Honda, Y. (1998). Hypoxia and vascular endothelial growth factor stimulate angiogenic integrin expression in bovine retinal microvascular endothelial cells. Invest. Ophthalmol. Vis. Sci. 39, 1028-1035.
64. Swerlick, R. A., Brown, E. J., Xu, Y., Lee, K. H., Manos, S. and Lawiey, T. J. (1992). Expression and modulation of the vitronectin receptor on human dermal microvascular endothelial cells. J. Invest. Dermatol. 99, 715-722.
65. 3 angiogenesis and apoptosis. Cell Adhesion Commun. 3, 367-374.
66. Yamada, K. M. and Geiger, B. (1997). Molecular interactions in cell adhesion complexes. Can. Opin. Cell Biol. 9, 76-85.
67. Yang, J. T., Rayburn, H. and Hynes, R. O. (1993). Embryonic mesodermal defects in α5 integrin-deficient mice. Development 119, 1093-1105.
68. 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc. Natl. Acad. Sci. USA 92, 6161-6165.